Advanced Therapies Summit London, March 18th-19th

Immuno UK London, April 25th-26th

An evening with Biognosys Oxford, March 12th-19th

SFTCG Nantes, March 22th

Contact Us
Contact Us

The Power of the
Immune Cells

Supporting developers of cell therapies, biologics and biomarkers

Next Generation Service Provider

Your Partner for Oncology
and Immune Related Diseases

Data driven tools, focused on immune and tumor cells, leveraging cutting edge wet labs experiment and AI-powered data science.
Our strengh: an Innovative business model, service provider and long term partnership with peers and biotech.

Biologists & Datascientists Team

  • 15+ years of experience
  • Flexible and Customized Protocols
  • Immunology Experts

Fully integrated Cell &
Molecular Biology

  • Cytometry & Cell Sorting
  • Select Omics Libraries Generation
  • ISO 9001 & 10x Certified

Omics Data Sciences

  • Confirmatory or Exploratory Studies
  • AI-powered Tools
  • TCR & BCR Databases

Wet Labs & Datascience Services

Integrated technological platform, dedicated to cell phenotyping, omics generation and data analysis

Boost Your Research Programs


Our different flow cytometry & omics solutions have the potential to boost research programs. Several fields of application can benefit from our immune expertise, including fundamental and translational research, such as immuno-oncology, infectious diseases, autoimmune and inflammatory diseases.

Look how Parean biotechnologies
supports researchers to drive discoveries

Explore Applications
More about us

Knowledge Hub

News, Publications & Application Notes

Discover our sciences and meet with us during upcoming conferences !

See more
  • Publication

    Plasma CD27, a Surrogate of the Intratumoral CD27–CD70 Interaction, Correlates with Immunotherapy Resistance in Renal Cell Carcinoma

    November 14, 2022

    Clinical Cancer Research - 2022

  • Publication

    Benchmarking of T cell Receptor repertoire profiling methods reveals large systematic biases

    September 7, 2020

    Nature Biotechnology - 2020

  • Publication

    A unique CD8+ T lymphocyte signature in pediatric type 1 diabetes

    September 1, 2016

    Journal of Autoimmunity - 2016

  • Publication

    Card9 mediates susceptibility to intestinal pathogens through microbiota modulation and control of bacterial virulence

    August 9, 2017

    GUT - 2017

  • Publication

    Cross-reactivity between tumor MHC class I–restricted antigens and an enterococcal bacteriophage

    August 21, 2020

    Science - 2020

  • Publication

    Dissecting the respective roles of microbiota and host genetics in the susceptibility of Card9 mice to colitis

    April 23, 2024

    Microbiome - 2024

  • Application Notes

    Bulk versus Single Cell Comparative advantages

    May 30, 2024


They support us